NCT06218420View on ClinicalTrials.gov

Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation

PHASE2RecruitingINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2027

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

Stereotactic Body Radiotherapy (SBRT)

Stereotactic Body Radiotherapy (SBRT) is a non-invasive alternative and potentially efficient treatment of single or bilocular HCC. However, SBRT has not been validated as bridging therapy before LT in a prospective study yet.

Trial Locations (1)

75013

RECRUITING

Service de chirurgie digestive, hépato-bilio-pancréatique et transplantation hépatique. Groupe Hospitalier Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER